
Vital Connect Inc, a US-based tech healthcare firm, specializes in wireless biosensor technology for cardiovascular disease management.
Vital Connect Inc, founded in San Jose, United States, is a technology-based healthcare company with a core mission to revolutionize cardiovascular disease management through innovative wireless biosensor technology. Their flagship product, the VitalPatch, offers comprehensive intelligent health measurements and remote patient monitoring, aiding in the detection, diagnosis, and treatment of cardiovascular conditions. The company focuses on providing solutions for healthcare professionals, hospitals, and clinical trials, enhancing patient care through advanced biomedical engineering and mobile/cloud software integration.
Notable figures affiliated with Vital Connect include experienced leaders in biomedical engineering and healthcare technology. The company has secured investments from prominent venture capital firms, contributing to its rapid growth and innovation. Key achievements include the successful deployment of their VitalPatch technology in various clinical settings, significantly improving patient outcomes and operational efficiencies. Overall, Vital Connect has made a substantial impact on the healthcare industry by advancing remote cardiac monitoring and chronic disease management.

Vivalink
vivalink.com

MyVitalz
myvitalz.com

Vital Metrix

AliveCor
alivecor.com

Ventricle Health Tech

Ventricle Health

HeartCloud
heartcloud.io

RTM Vital Signs
rtmvitalsigns.com

Vena Vitals
venavitals.com

Validic
validic.com

VivaQuant
vivaquant.com

Cardiomems

iRhythm
irhythmtech.com

CardieX
cardiex.com

Pace mate
pacemate.com
Companies similar to Vital Connect include Vivalink, MyVitalz, Vital Metrix and AliveCor.
Vital Connect was founded in 2011.
Vital Connect's headquarters is located in San Jose, CA, US.
Vital Connect's most recent funding round was for $30M (USD) in July 2023.
As of Jul 18, 2023, Vital Connect has raised a total of $178.9M (USD).
Vital Connect has 143 employees as of Feb 5, 2024.